VACY AS |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| - PTS | -.--% |
|
-.--% | -.--% |
| 14/05 | Transcript : Nykode Therapeutics AS, Q1 2024 Earnings Call, May 14, 2024 | |
| 14/05 | Nykode Therapeutics AS Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Evolution of the average Target Price on VACY AS
Price target over the last 5 years
History of analyst recommendation changes
72fe3de3dd1f5c2b6b0b25.NU5LamHt6THzTY4hW2D_1iqPNtAQ2xGFuExm3yQqE4w.XzwiWjmOh27LAPsUOiLP52vIeeVi4kjc8zUT5nB_XN9xFztfBpe2Xr4i1w~3afa7081647ac7ea4cc45d9926363ef7
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
14.73
NOK
Average target price
43
NOK
Spread / Average Target
+191.92%
High Price Target
70
NOK
Spread / Highest target
+375.22%
Low Price Target
28
NOK
Spread / Lowest Target
+90.09%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
EPS Revisions
- Stock Market
- Equities
- VACC Stock
- VACC Stock
- Consensus VACY AS
